Task: Answer the multiple choice question.
Query: Which drug exhibits a 1.564% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] COc1cccc(N2CCN(CC(=O)Nc3ccccc3C(=O)NCc3ccccc3)CC2)c1
[b] COc1cccc(NC(=O)CCNS(=O)(=O)c2cccc3nsnc23)c1
[c] C/C(=N\NC(=O)C(=O)N/N=C(\C)c1cccc(O)c1)c1cccc(O)c1
Answer: b. COc1cccc(NC(=O)CCNS(=O)(=O)c2cccc3nsnc23)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(NC(=O)CCNS(=O)(=O)c2cccc3nsnc23)c1
COc1cccc(NC(=O)CCNS(=O)(=O)c2cccc3nsnc23)c1
3-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-(5-methoxyphenyl)propanamide